loading
Bolt Biotherapeutics Inc stock is traded at $0.578, with a volume of 11,252. It is up +1.40% in the last 24 hours and down -9.35% over the past month. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$0.57
Open:
$0.5655
24h Volume:
11,252
Relative Volume:
0.08
Market Cap:
$22.15M
Revenue:
$7.88M
Net Income/Loss:
$-69.20M
P/E Ratio:
-0.2833
EPS:
-2.04
Net Cash Flow:
$-69.73M
1W Performance:
-7.13%
1M Performance:
-9.35%
6M Performance:
-25.42%
1Y Performance:
-33.18%
1-Day Range:
Value
$0.5513
$0.585
1-Week Range:
Value
$0.54
$0.6224
52-Week Range:
Value
$0.54
$1.56

Bolt Biotherapeutics Inc Stock (BOLT) Company Profile

Name
Name
Bolt Biotherapeutics Inc
Name
Phone
650-665-9295
Name
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Name
Employee
100
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
BOLT's Discussions on Twitter

Compare BOLT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
BOLT 0.578 22.15M 7.88M -69.20M -69.73M -2.04
VRTX 448.66 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.45 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.56 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.89 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.27 24.49B 3.30B -501.07M 1.03B 11.54

Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-06-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-02-21 Initiated Guggenheim Buy
Mar-02-21 Initiated Morgan Stanley Overweight
Mar-02-21 Initiated SVB Leerink Outperform
Mar-02-21 Initiated Stifel Buy

Bolt Biotherapeutics Inc Stock (BOLT) Latest News

pulisher
Nov 19, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.54 By Investing.com - Investing.com Canada

Nov 19, 2024
pulisher
Nov 19, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.54 - Investing.com

Nov 19, 2024
pulisher
Nov 16, 2024

HC Wainwright Issues Pessimistic Forecast for BOLT Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look - TipRanks

Nov 14, 2024
pulisher
Nov 13, 2024

Bolt Biotherapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024
pulisher
Nov 12, 2024

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024
pulisher
Nov 09, 2024

Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation - Yahoo Finance

Nov 09, 2024
pulisher
Nov 07, 2024

BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting - The Manila Times

Nov 07, 2024
pulisher
Nov 05, 2024

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Marketscreener.com

Nov 05, 2024
pulisher
Nov 02, 2024

Bolt Biotherapeutics (STU:6LP) Cash Flow from Investing : €52.47 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Oct 30, 2024

Breast Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Oct 30, 2024
pulisher
Oct 22, 2024

BOLT Stock Surges Over 5% Amidst Biotech Sector's Mixed Performa - GuruFocus.com

Oct 22, 2024
pulisher
Oct 18, 2024

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances - Citeline

Oct 18, 2024
pulisher
Oct 16, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Broad Biotech Indu - GuruFocus.com

Oct 16, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Sells 240,898 Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Has $208,000 Stock Holdings in Hesai Group (NASDAQ:HSAI) - Defense World

Oct 13, 2024
pulisher
Oct 12, 2024

Short Interest in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Drops By 39.1% - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Just Auto Excellence Awards 2024: TomTom - just-auto.com

Oct 11, 2024
pulisher
Oct 07, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Vol - GuruFocus.com

Oct 07, 2024
pulisher
Sep 28, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 14.2% in September - Defense World

Sep 28, 2024
pulisher
Sep 24, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.61 By Investing.com - Investing.com Canada

Sep 24, 2024
pulisher
Sep 24, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.61 - Investing.com

Sep 24, 2024
pulisher
Sep 19, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Significant Decrease in Short Interest - Defense World

Sep 19, 2024
pulisher
Sep 07, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.65 By Investing.com - Investing.com Australia

Sep 07, 2024
pulisher
Sep 06, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.65 - Investing.com

Sep 06, 2024
pulisher
Sep 05, 2024

Bolt Biotherapeutics Announces Changes to its Board of Directors - ForexTV.com

Sep 05, 2024
pulisher
Sep 04, 2024

Bolt Biotherapeutics reshuffles board, appoints new chair By Investing.com - Investing.com Canada

Sep 04, 2024
pulisher
Sep 04, 2024

Bolt Biotherapeutics reshuffles board, appoints new director - Investing.com

Sep 04, 2024
pulisher
Sep 04, 2024

Bolt Biotherapeutics Announces Board Reshuffle and New Appointment - TipRanks

Sep 04, 2024
pulisher
Sep 03, 2024

Deadline on Sept. 3rd coming up in Lawsuit for Investors in shares of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) - openPR

Sep 03, 2024
pulisher
Sep 03, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesBOLT - PR Newswire

Sep 03, 2024
pulisher
Sep 03, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Sep 03, 2024
pulisher
Sep 02, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the - EIN News

Sep 02, 2024
pulisher
Sep 02, 2024

BOLT Investors Have the Opportunity to Lead Bolt - GlobeNewswire

Sep 02, 2024
pulisher
Sep 02, 2024

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Sep 02, 2024
pulisher
Sep 02, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.

Sep 02, 2024
pulisher
Sep 01, 2024

BOLT DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire

Sep 01, 2024
pulisher
Aug 31, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - The Malaysian Reserve

Aug 31, 2024
pulisher
Aug 31, 2024

BOLT Deadline: BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

Aug 31, 2024
pulisher
Aug 30, 2024

BOLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Aug 30, 2024
pulisher
Aug 30, 2024

BOLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Aug 30, 2024
pulisher
Aug 30, 2024

Finansavisen - Finansavisen

Aug 30, 2024

Bolt Biotherapeutics Inc Stock (BOLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):